These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 25256751)

  • 1. Discrepancies in cancer genomic sequencing highlight opportunities for driver mutation discovery.
    Hudson AM; Yates T; Li Y; Trotter EW; Fawdar S; Chapman P; Lorigan P; Biankin A; Miller CJ; Brognard J
    Cancer Res; 2014 Nov; 74(22):6390-6396. PubMed ID: 25256751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exome-wide Sequencing Shows Low Mutation Rates and Identifies Novel Mutated Genes in Seminomas.
    Cutcutache I; Suzuki Y; Tan IB; Ramgopal S; Zhang S; Ramnarayanan K; Gan A; Lee HH; Tay ST; Ooi A; Ong CK; Bolthouse JT; Lane BR; Anema JG; Kahnoski RJ; Tan P; Teh BT; Rozen SG
    Eur Urol; 2015 Jul; 68(1):77-83. PubMed ID: 25597018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exome sequencing reveals comprehensive genomic alterations across eight cancer cell lines.
    Chang H; Jackson DG; Kayne PS; Ross-Macdonald PB; Ryseck RP; Siemers NO
    PLoS One; 2011; 6(6):e21097. PubMed ID: 21701589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lung cancer molecular testing, what role for Next Generation Sequencing and circulating tumor DNA].
    Pécuchet N; Legras A; Laurent-Puig P; Blons H
    Ann Pathol; 2016 Jan; 36(1):80-93. PubMed ID: 26803564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole-exome sequencing combined with functional genomics reveals novel candidate driver cancer genes in endometrial cancer.
    Liang H; Cheung LW; Li J; Ju Z; Yu S; Stemke-Hale K; Dogruluk T; Lu Y; Liu X; Gu C; Guo W; Scherer SE; Carter H; Westin SN; Dyer MD; Verhaak RG; Zhang F; Karchin R; Liu CG; Lu KH; Broaddus RR; Scott KL; Hennessy BT; Mills GB
    Genome Res; 2012 Nov; 22(11):2120-9. PubMed ID: 23028188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exome-Scale Discovery of Hotspot Mutation Regions in Human Cancer Using 3D Protein Structure.
    Tokheim C; Bhattacharya R; Niknafs N; Gygax DM; Kim R; Ryan M; Masica DL; Karchin R
    Cancer Res; 2016 Jul; 76(13):3719-31. PubMed ID: 27197156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic characterization of biliary tract cancers identifies driver genes and predisposing mutations.
    Wardell CP; Fujita M; Yamada T; Simbolo M; Fassan M; Karlic R; Polak P; Kim J; Hatanaka Y; Maejima K; Lawlor RT; Nakanishi Y; Mitsuhashi T; Fujimoto A; Furuta M; Ruzzenente A; Conci S; Oosawa A; Sasaki-Oku A; Nakano K; Tanaka H; Yamamoto Y; Michiaki K; Kawakami Y; Aikata H; Ueno M; Hayami S; Gotoh K; Ariizumi SI; Yamamoto M; Yamaue H; Chayama K; Miyano S; Getz G; Scarpa A; Hirano S; Nakamura T; Nakagawa H
    J Hepatol; 2018 May; 68(5):959-969. PubMed ID: 29360550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing.
    Koboldt DC; Zhang Q; Larson DE; Shen D; McLellan MD; Lin L; Miller CA; Mardis ER; Ding L; Wilson RK
    Genome Res; 2012 Mar; 22(3):568-76. PubMed ID: 22300766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of 7,815 cancer exomes reveals associations between mutational processes and somatic driver mutations.
    Poulos RC; Wong YT; Ryan R; Pang H; Wong JWH
    PLoS Genet; 2018 Nov; 14(11):e1007779. PubMed ID: 30412573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of novel mutations by exome sequencing in African American colorectal cancer patients.
    Ashktorab H; Daremipouran M; Devaney J; Varma S; Rahi H; Lee E; Shokrani B; Schwartz R; Nickerson ML; Brim H
    Cancer; 2015 Jan; 121(1):34-42. PubMed ID: 25250560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of new driver and passenger mutations within APOBEC-induced hotspot mutations in bladder cancer.
    Shi MJ; Meng XY; Fontugne J; Chen CL; Radvanyi F; Bernard-Pierrot I
    Genome Med; 2020 Sep; 12(1):85. PubMed ID: 32988402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and analysis of mutational hotspots in oncogenes and tumour suppressors.
    Baeissa H; Benstead-Hume G; Richardson CJ; Pearl FMG
    Oncotarget; 2017 Mar; 8(13):21290-21304. PubMed ID: 28423505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statistically identifying tumor suppressors and oncogenes from pan-cancer genome-sequencing data.
    Kumar RD; Searleman AC; Swamidass SJ; Griffith OL; Bose R
    Bioinformatics; 2015 Nov; 31(22):3561-8. PubMed ID: 26209800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequencing approaches in cancer treatment.
    Sekar D; Thirugnanasambantham K; Hairul Islam VI; Saravanan S
    Cell Prolif; 2014 Oct; 47(5):391-5. PubMed ID: 25131793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IDENTIFY CANCER DRIVER GENES THROUGH SHARED MENDELIAN DISEASE PATHOGENIC VARIANTS AND CANCER SOMATIC MUTATIONS.
    Ma M; Wang C; Glicksberg BS; Schadt EE; Li SD; Chen R
    Pac Symp Biocomput; 2017; 22():473-484. PubMed ID: 27896999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exome sequencing of oral squamous cell carcinoma in users of Arabian snuff reveals novel candidates for driver genes.
    Al-Hebshi NN; Li S; Nasher AT; El-Setouhy M; Alsanosi R; Blancato J; Loffredo C
    Int J Cancer; 2016 Jul; 139(2):363-72. PubMed ID: 26934577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A computational approach to distinguish somatic vs. germline origin of genomic alterations from deep sequencing of cancer specimens without a matched normal.
    Sun JX; He Y; Sanford E; Montesion M; Frampton GM; Vignot S; Soria JC; Ross JS; Miller VA; Stephens PJ; Lipson D; Yelensky R
    PLoS Comput Biol; 2018 Feb; 14(2):e1005965. PubMed ID: 29415044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Personalized genomic analyses for cancer mutation discovery and interpretation.
    Jones S; Anagnostou V; Lytle K; Parpart-Li S; Nesselbush M; Riley DR; Shukla M; Chesnick B; Kadan M; Papp E; Galens KG; Murphy D; Zhang T; Kann L; Sausen M; Angiuoli SV; Diaz LA; Velculescu VE
    Sci Transl Med; 2015 Apr; 7(283):283ra53. PubMed ID: 25877891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of novel mutations in endometrial cancer patients by whole-exome sequencing.
    Chang YS; Huang HD; Yeh KT; Chang JG
    Int J Oncol; 2017 May; 50(5):1778-1784. PubMed ID: 28339086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Copy number losses of oncogenes and gains of tumor suppressor genes generate common driver mutations.
    Besedina E; Supek F
    Nat Commun; 2024 Jul; 15(1):6139. PubMed ID: 39033140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.